At IMeBIO, we possess the technical know-how and state-of-the-art resources to both design and build mobile BSL2 and BSL3 labs offering plug-and-play deployment.
Through our joint venture with LCCA, we leverage the HI-MACS® synthetic resin developed by LG Chem to manufacture flexible yet robust wall and ceiling panels for our mobile labs. HI-MACS® technology also lets us build customized labs designed to meet your specific needs or constraints.
We also draw on a wide range of outside experts to bring in specialized know-how and new perspectives on infectious diseases.
François Martin, Vice President of R&D and Head of New Lab Design
François currently leads the Infectious Disease Center at the Lyonbiopole competitive cluster in Lyon, France. He worked for bioMérieux from 1989 to 2007, heading the Infrastructure, Healthcare, Safety, and Environmental Division at the Christophe Mérieux Center-bioMérieux's Grenoble-based R&D center for molecular biology and microsystems-from 2006 to 2007. He managed a major infrastructure project at the Christophe Mérieux Center from 2004 to 2005. From 1998 to 2003, François headed maintenance and infrastructure activities at bioMérieux's first molecular biology R&D center in Lyon.
This experience gave François the skills needed to design BSL2 and BSL3 biological containment labs and oversee their construction, both in France and, thanks to his work for bioMérieux and the Christophe and Rodolphe Mérieux Foundation, around the world.
Jean-François Jung, Chief Executive Officer
Jean-François is also CEO of Climatic, a 10-person company he set up in 2006. Before founding Climatic he worked as a senior business development manager at Trindel from 2000 to 2006, where he gained valuable experience in laboratory processes like air and process fluid treatment to complement his solid business management know-how.
Yves Laurent, Chairman
Yves is currently President of the Lyonbiopole competitive cluster in Lyon, France. He previously headed the Christophe Mérieux Center, bioMérieux's Grenoble-based R&D center for molecular biology and microsystems, after serving as Vice President of bioMérieux's Advanced Technology Division. In 1994 Yves created Genome Express, a DNA sequencing company, which he ran until 2003 (today the company is called Cogenics). He served as President of the Rhône-Alpes Agency for the Development of Medical and Bio-Technology from 2001 to 2004. Yves also has extensive field experience thanks to his work at Sanofi and Applied Biosystems.